Discovery of potent and orally available small molecule inhibitors of the SOS1-KRAS interaction

被引：0
|
作者：
Yu, Ha Na
Ki, Dong Hyuk
Nam, Joonwoo
Kim, Eun-Jung
Kim, Sungeun
Choi, Hunmi
Kim, Jieun
Yu, Jihyun
Kim, Donggeon
Park, Dohyun
Yoon, Kyeong Jin
Jo, Seongin
Hwang, So-Hyeon
Lim, Sang Kyun
Shin, Young Sook
Han, Wooseok
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-515
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
515
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Inhibitors of CDK8 for the Treatment of Cancer
    Li, Yangguang
    Liu, Yingtao
    Wu, Jianping
    Liu, Xiaosong
    Wang, Lin
    Wang, Ju
    Yu, Jiaojiao
    Qi, Hongyun
    Qin, Luoheng
    Ding, Xiao
    Ren, Feng
    Zhavoronkov, Alex
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (08) : 5439 - 5452
  • [22] Discovery of potent and orally available malonyl- CoA decarboxylase inhibitors as cardioprotective agents
    Cheng, Jie-Fei
    Huang, Yujin
    Penuliar, Richard
    Nishimoto, Masahiro
    Liu, Larry
    Arrhenius, Thomas
    Yang, Guang
    O'Leary, Eoin
    Barbosa, Miguel
    Barr, Rick
    Dyck, Jason R. B.
    Lopaschuk, Gary D.
    Nadzan, Alex M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (14) : 4055 - 4058
  • [23] Design and Discovery of MRTX0902, a Potent, Selective, Brain- Penetrant, and Orally Bioavailable Inhibitor of the SOS1:KRAS Protein-Protein Interaction
    Ketcham, John M.
    Haling, Jacob
    Khare, Shilpi
    Bowcut, Vickie
    Briere, David M.
    Burns, Aaron C.
    Gunn, Robin J.
    Ivetac, Anthony
    Kuehler, Jon
    Kulyk, Svitlana
    Laguer, Jade
    Lawson, J. David
    Moya, Krystal
    Nguyen, Natalie
    Rahbaek, Lisa
    Saechao, Barbara
    Smith, Christopher R.
    Sudhakar, Niranjan
    Thomas, Nicole C.
    Vegar, Laura
    Vanderpool, Darin
    Wang, Xiaolun
    Yan, Larry
    Olson, Peter
    Christensen, James G.
    Marx, Matthew A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, : 9678 - 9690
  • [24] Discovery of RGT-018: A potent, selective and orally bioavailable SOS1 inhibitor for mutant KRAS-driven cancers
    Xiao, Fei
    Wang, Kailiang
    Wang, Xinjuan
    Li, Huijuan
    Hu, Zhilong
    Huang, Wei
    Ren, Xiaoming
    Feng, Teng
    Yao, Lili
    Lin, Jing
    Li, Chunlai
    Mei, Liufeng
    Zhang, Zhuanzhuan
    Liu, Yangyang
    Chen, Xi
    Zhu, Xiaotian
    Zhong, Wenge
    Xie, Zhi
    CANCER RESEARCH, 2023, 83 (07)
  • [25] Discovery of Potent Small-Molecule Inhibitors of MLL Methyltransferase
    Chern, Ting-Rong
    Liu, Liu
    Petrunak, Elyse
    Stuckey, Jeanne A.
    Wang, Mi
    Bernard, Denzil
    Zhou, Haibin
    Lee, Shirley
    Dou, Yali
    Wang, Shaomeng
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (06): : 1348 - 1352
  • [26] Discovery of potent small-molecule inhibitors of lipoprotein(a) formation
    Diaz, Nuria
    Perez, Carlos
    Escribano, Ana Maria
    Sanz, Gema
    Priego, Julian
    Lafuente, Celia
    Barberis, Mario
    Calle, Luis
    Espinosa, Juan Felix
    Priest, Birgit T.
    Zhang, Hong Y.
    Nosie, Amanda K.
    Haas, Joseph V.
    Cannady, Ellen
    Borel, Anthony
    Schultze, Albert E.
    Sauder, J. Michael
    Hendle, Joerg
    Weichert, Ken
    Nicholls, Stephen J.
    Michael, Laura F.
    NATURE, 2024, 629 (8013) : 945 - 950
  • [27] Discovery of orally available and potent MPS1(TTK) kinase inhibitors for anti-cancer drugs
    Lee, Younho
    Kang, Juhee
    Kang, Sein
    Kim, Hyunkyung
    Seo, Kyung-ah
    Choi, Jieun
    Ahn, Jaeyoung
    Son, Jung Beom
    Kim, Nam Doo
    CANCER RESEARCH, 2019, 79 (13)
  • [28] Discovery of potent small molecule inhibitors of Wnt-dependent transcription
    Mallinger, Aurelie
    Crumpler, Simon
    Pichowicz, Mark
    Waalboer, Dennis
    Raynaud, Florence
    Rohdich, Felix
    Georgi, Katrin
    Stubbs, Mark
    Aherne, Wynne
    Dale, Trevor
    Wienke, Dirk
    Stieber, Frank
    Schiemann, Kai
    Blagg, Julian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [29] Inhibitors of MPS1: Discovery of CCT289346, a highly potent, selective and orally available preclinical candidate
    Woodward, Hannah L.
    Innocenti, Paolo
    Cheung, Kwai-Ming J.
    Naud, Sebastien
    Hayes, Angela
    Henley, Alan T.
    Faisal, Amir
    Mak, Grace
    Box, Gary
    Westwood, Isaac M.
    Carter, Michael
    Valenti, Melanie
    Brandon, Alexis De Haven
    O'Fee, Lisa
    Saville, Harry
    Burke, Rosemary
    Van Montfort, Rob
    Raynaud, Florence
    Eccles, Suzanne A.
    Linardopoulos, Spiros
    Blagg, Julian
    Hoelder, Swen
    CANCER RESEARCH, 2017, 77
  • [30] Discovery of potent small molecule inhibitors of histone lysine methyltransferase NSDs
    Piao, Lianhua
    Gao, Ying
    Xu, Xiaoshuang
    Su, Yangyang
    Wang, Yanong Daniel
    Zhou, Jie
    Gao, Yang
    Fang, Jin
    Li, Qihui
    Chang, Shan
    Kong, Ren
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 268
12345